Quest for Research Freedom Fuels African Biotech Boom
Quest for Research Freedom Fuels African Biotech Boom
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Quest for Research Freedom Fuels African Biotech Boom
Quest for Research Freedom Fuels African Biotech Boom

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

industry
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study
Jef Akst | Sep 3, 2020
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Amanda Heidt | Aug 26, 2020
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
It Takes Less Than 30 Days to Compost a Human Body
It Takes Less Than 30 Days to Compost a Human Body
Jef Akst | Feb 17, 2020
In a small trial of deceased volunteers, a Seattle-based company called Recompose demonstrates that its method for “natural organic reduction” of a human body completely breaks down soft tissue.
Opinion: Taxpayers Should Cover Portion of Patent Costs
Opinion: Taxpayers Should Cover Portion of Patent Costs
Paul R. Sanberg | Oct 9, 2019
Federal grant support for technology transfer at universities will strengthen the national innovation system.
California Seeks to Ban Chlorpyrifos-Containing Pesticides
California Seeks to Ban Chlorpyrifos-Containing Pesticides
Jef Akst | May 9, 2019
The state’s Environmental Protection Agency says that evidence of the chemical’s link to neurological problems in children is overwhelming.
Miracle Elixirs
Miracle Elixirs
Bob Grant | Apr 1, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
How to Successfully Collaborate with Industry
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
Can Young Stem Cells Make Older People Stronger?
Can Young Stem Cells Make Older People Stronger?
Shawna Williams | Dec 11, 2017
Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 
Editors Claim Censorship at a Public Health Journal
Editors Claim Censorship at a Public Health Journal
Jef Akst | Nov 21, 2017
The editorial board at the International Journal of Occupational and Environmental Health accuses its publisher of promoting corporate interests.
2017 Life Science Salary Survey
2017 Life Science Salary Survey
Aggie Mika | Nov 1, 2017
Industry professionals make more than academic researchers, but for professors, it may not be about the money.
Opinion: Tales from the Nonacademic Career Path
Opinion: Tales from the Nonacademic Career Path
Anna Kriebs | Sep 2, 2017
Graduate students from The Scripps Research Institute share how they prepared to enter policy, law, biotech, and beyond.
Gilead to Pay Nearly $12B for CAR T-Cell Company
Gilead to Pay Nearly $12B for CAR T-Cell Company
Jef Akst | Aug 28, 2017
The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.
Life Science Leaders Meet at White House
Life Science Leaders Meet at White House
Kerry Grens | May 8, 2017
Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.
National Academies Revise Conflict of Interest Policy
National Academies Revise Conflict of Interest Policy
Ashley P. Taylor | May 3, 2017
The proposed changes follow revelations in recent years that committee members preparing reports for the Academies did not disclose industry relationships. 
Drug Approval Timeline Same as 20 Years Ago
Drug Approval Timeline Same as 20 Years Ago
Kerry Grens | Jan 9, 2017
A report finds that new medications still take about 12 years to go from patent to patient.
Addressing Biomedical Science’s PhD Problem
Addressing Biomedical Science’s PhD Problem
Catherine Offord | Jan 1, 2017
Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.